Home
>
National Drug Code (NDC)
>
Brevibloc
Brevibloc - 10019-075-87 - (Esmolol Hydrochloride)
Drug Information of Brevibloc
| Product NDC: | 10019-075 |
| Proprietary Name: | Brevibloc |
| Non Proprietary Name: | Esmolol Hydrochloride |
| Active Ingredient(s): | 20 mg/mL & nbsp; Esmolol Hydrochloride |
| Administration Route(s): | INTRAVENOUS |
| Dosage Form(s): | INJECTION |
| Coding System: | National Drug Codes(NDC) |
Labeler Information of Brevibloc
| Product NDC: | 10019-075 |
| Labeler Name: | Baxter Healthcare Corporation |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | NDA019386 |
| Marketing Category: | NDA |
| Start Marketing Date: | 19861231 |
Package Information of Brevibloc
| Package NDC: | 10019-075-87 |
| Package Description: | 100 mL in 1 BAG (10019-075-87) |
NDC Information of Brevibloc
| NDC Code | 10019-075-87 |
| Proprietary Name | Brevibloc |
| Package Description | 100 mL in 1 BAG (10019-075-87) |
| Product NDC | 10019-075 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | Esmolol Hydrochloride |
| Dosage Form Name | INJECTION |
| Route Name | INTRAVENOUS |
| Start Marketing Date | 19861231 |
| Marketing Category Name | NDA |
| Labeler Name | Baxter Healthcare Corporation |
| Substance Name | ESMOLOL HYDROCHLORIDE |
| Strength Number | 20 |
| Strength Unit | mg/mL |
| Pharmaceutical Classes | Adrenergic beta-Antagonists [MoA],beta-Adrenergic Blocker [EPC] |
